Showing 2471-2480 of 3137 results for "".
- Marini SkinSolutions Launches Topical Serum to Complement Neuromodulator Injectionshttps://modernaesthetics.com/news/marini-skinsolutions-launches-topical-serum-to-complement-neuromodulator-injections/2483956/Marini SkinSolutions™ has introduced NeuroSmooth™, a topical peptide-based serum formulated to support and enhance outcomes associated with neuromodulator injections. The serum contains neuromodulating peptides, collagen stimulators, and ingredients aimed at improvi
- Natural Refinement, Early Intervention Define 2026 Aesthetic Trends, Says Dr Anil Shahhttps://modernaesthetics.com/news/natural-refinement-early-intervention-define-2026-aesthetic-trends-says-dr-anil-shah/2483940/Facial plastic surgeon Anil Shah, MD, outlined six key trends shaping aesthetic surgery in 2026 in a recent press release, reflecting a shift toward holistic, age-conscious, and safety-driven approaches. A full-face rejuvenation approach is supplanting isolated interventions, according to
- Registration Open for 2026 Octane Aesthetics Tech Forumhttps://modernaesthetics.com/news/registration-open-for-2026-octane-aesthetics-tech-forum/2483870/Aesthetic executives, leading physicians, and entrepreneurs will dive into the latest trends and technology in aesthetic medicine at the 2026 Octane Aesthetics Tech Forum. The 2-day forum will be held January 8-9 at the Pendry in Newport Beach, California. The agenda includes sessions on
- GLP-1 Demand Holds Steady in Aesthetic Clinics Despite Regulatory Shiftshttps://modernaesthetics.com/news/glp-1-demand-holds-steady-in-aesthetic-clinics-despite-regulatory-shifts/2483599/Despite regulatory uncertainty and reported shortages, aesthetic practices continue to experience high demand for glucagon-like peptide-1 (GLP-1) receptor agonists, according to a report released by Guidepoint Qsight on October 1, 2025.
- CollPlant Advances Light-Activated Regenerative Filler Toward Clinical Trialshttps://modernaesthetics.com/news/collplant-advances-light-activated-regenerative-filler-toward-clinical-trials/2483589/CollPlant Biotechnologies has announced the completion of a nonclinical program supporting the development of its photocurable dermal filler, which combines hyaluronic acid with a modified form of recombinant human collagen (rhCollagen). The company plans to advanc
- Study Evaluates Ready-To-Use Botox for Lateral Canthal, Glabellar Lines Treatmenthttps://modernaesthetics.com/news/study-evaluates-ready-to-use-botox-for-lateral-canthal-glabellar-lines-treatment/2483549/Newly published research in Dermatologic Surgery found liquid nivobotulinumtoxinA was effective and well-tolerated in treating moderate-to-severe lateral canthal lines (LCLs) and glabellar lines (GLs). Jean Carruthers, MD, FRCSC, FRC, co-authored the study, titled “NivobotulinumtoxinA in
- Epicutis Launches Lipid Shield SPF 30https://modernaesthetics.com/news/epicutis-launches-lipid-shield-spf-30/2483432/Epicutis has launched a mineral-based sunscreen, Lipid Shield SPF 30. In a press release, the company stated the Lipid Shield SPF 30 is the only sunscreen to pair non-nano zinc oxide with a proprietary molecule known as disodium tetramethylhexadecenyl succinoyl cysteine (TSC). TSC, a lipid
- Daxxify® Surpasses 1 Million Vials Distributed in US Aesthetic Markethttps://modernaesthetics.com/news/daxxify-surpasses-1-million-vials-distributed-in-us-aesthetic-market/2483419/Revance Therapeutics has announced the distribution of more than 1 million vials of daxibotulinumtoxinA-lanm (Daxxify®) for aesthetic use in the United States, marking a notable milestone 3 years after the product received US Food and Drug Administration (FDA) approval. According to a pres
- Hugel Marks 15 Years of Letybo with 2025 H.E.L.F Symposium in Seoulhttps://modernaesthetics.com/news/hugel-marks-15-years-of-letybo-with-2025-helf-symposium-in-seoul/2483385/More than 220 medical professionals from across the globe gathered in Seoul on September 14 for Hugel Inc.’s 2025 H.E.L.F. symposium, marking 15 years since the launch of its botulinum toxin, Letybo. The Hugel Expert Leader’s Forum was held at Seoul Dragon City under the theme, “K-Beau
- Study Finds Abdominoplasty Can Help Improve Urinary Incontinence Symptomshttps://modernaesthetics.com/news/study-finds-abdominoplasty-can-help-improve-urinary-incontinence-symptoms/2483374/A new study published in Aesthetic Plastic Surgery reports that abdominoplasty may contribute to improvement in urinary incontinence symptoms. The study titled “Can Abdominoplasty Relieve Symptoms of Urinary Incontinence?” systematically reviewed the existing literature to evaluate the f